Pharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.
Distinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.
Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Adequate training will help them recognize signs of misuse and assist with preventive measures.
When pharmacists are involved in the care process, they can address common barriers to medication use, such as polypharmacy, ineffective medication, high costs, health and lifestyle considerations, and social needs.
Improving patient safety and reducing harmful events is a team effort that includes both executive leadership and management as well as front line care teams.
DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.
Pharmacists play an important role in managing patients with this complex condition.
Studies suggest bipolar disorder is associated with increased potential for stroke and higher odds of experiencing poor outcomes.
Several studies on valerian have been conducted in the past 50 years for indications varying from insomnia, anxiety, restless leg syndrome, headaches, and more.
Treatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Pharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products.
Tildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.
Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.
Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.
Approximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.
Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Carrie Koenigsfeld, PharmD, FAPhA, discusses examples of successful community outreach initiatives aimed at overcoming barriers to adult RSV vaccination.
Africa’s rapidly growing population, expected to reach 2.5 billion by 2050, means an increasing demand for health care and medications.
At a time when pharmacist burnout and turnover is higher than ever before, talent retention is increasingly a strategic imperative for hospitals.
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
The pandemic’s aftermath left lasting tensions in health care.
Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.
But the role of the pharmacy chain in health systems, primary care, and specialty is uncertain.
In light of the growing numbers of students opting for post-graduate trainings, colleges and schools of pharmacy may want to consider offering electives geared toward exposing students to post-graduate career possibilities and provide guidance toward success.
This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.